Line 43: | Line 43: | ||
<li> | <li> | ||
<a href="https://2016.igem.org/Team:MIT/Diagnosis_and_Future_Implications"> | <a href="https://2016.igem.org/Team:MIT/Diagnosis_and_Future_Implications"> | ||
− | <img src="https://static.igem.org/mediawiki/2016/6/64/T--MIT--FutureButton.svg" alt="Future work, designs, and collaborations" > | + | <img src="https://static.igem.org/mediawiki/2016/6/64/T--MIT--FutureButton.svg" alt="Future work, designs, and collaborations" width="950px" > |
<span class="text-content"><span><br><br><br><br><br><br><br><br><br><br><br><br><br><br>Read more about the future of our work through circuit design, clinical application, and iGEM collaborations<br><br></span></span> | <span class="text-content"><span><br><br><br><br><br><br><br><br><br><br><br><br><br><br>Read more about the future of our work through circuit design, clinical application, and iGEM collaborations<br><br></span></span> | ||
</a> | </a> |
Revision as of 03:06, 17 October 2016
This diagnostic process can be expedited with synthetic biological tools that sense the following molecular markers in endometrial biopsy samples.
-
Read more about how we created synthetic promoters to respond to this disease marker
-
Read more about how we characterized miRNA profiles in model cells under varying conditions
-
Read more about how we characterized recombinases that could give a circuit memory across a cycle